AAOS updates clinical practice guidelines for glenohumeral joint osteoarthritis
Click Here to Manage Email Alerts
The American Academy of Orthopaedic Surgeons has released updates to its glenohumeral joint osteoarthritis clinical practice guidelines, including new trends, evidence and treatment recommendations.
“The guideline is timely as the disease burden of patients who may need treatment for glenohumeral joint osteoarthritis is increasing as the population ages,” according to the AAOS press release.
Highlights of the new clinical practice guidelines (CPG) are as follows:
- No benefit to the use of hyaluronic acid in the treatment of glenohumeral joint OA;
- Gender is not associated with better or worse postoperative outcomes;
- Anatomic total shoulder arthroplasty demonstrates more favorable function and pain relief in the short- to mid-term follow-up when compared to hemiarthroplasty;
- Clinicians may utilize pegged or keeled glenoid components in patients with glenohumeral joint osteoarthritis and a well-functioning rotator cuff;
- Older age at the time of surgery is associated with lower revision rates; and
- There is limited evidence that clinicians may utilize stemmed, stemless or resurfacing prosthesis for patients with glenohumeral joint OA.
The release also noted that the CPG is the product of “strong or moderate evidence” and in the absence of such evidence, “injectable biologics such as stem cells or platelet-rich plasma cannot be recommended for treatment.”
Lastly, the CPG suggests opioid prescription should not be a routine, long-term solution for pain management, according to the release. Physical therapy is the recommended alternative.
Reference: